The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model (Q80078223)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

The new malononitrilamide immunosuppressant FK778 prolongs corneal allograft survival in the rat keratoplasty model (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

F Birnbaum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

J Schwartzkopff

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

C Scholz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

A Reis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

T Reinhard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

30 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

1516-1523

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17401326%20AND%20SRC:MED&resulttype=core&format=json

The interaction between FK778 and tacrolimus in the prevention of rat cardiac allograft rejection is dose dependent

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Immunosuppression with FK778 and mycophenolate mofetil in a rat cardiac transplantation model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

The effects of FK778 in combination with tacrolimus and steroids: a phase II multicenter study in renal transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Mechanisms of action of mycophenolate mofetil in preventing chronic rejection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Mycophenolate mofetil and FK506: two novel immunosuppressants in murine corneal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Effect of mycophenolate mofetil, cyclosporin A, and both in combination in a murine corneal graft rejection model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Immunosuppression with cyclosporine A and mycophenolate mofetil after penetrating high-risk keratoplasty: a retrospective study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

FTY720 prolongs clear corneal allograft survival with a differential effect on different lymphocyte populations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Coadministration of the new macrolide immunosuppressant RAD and mycophenolate mofetil in experimental corneal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Anterior chamber-associated immune deviation, ocular immune privilege, and orthotopic corneal allografts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

The use of cyclosporine in high-risk keratoplasty.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Systemic ciclosporin A in high-risk keratoplasties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

[Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor]

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Leflunomide therapy following penetrating keratoplasty in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

Inhibition of human dendritic cell maturation and function by the novel immunosuppressant FK778.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

The malononitrilamide FK778 inhibits activation of NF-kappaB in human dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

FK778 attenuates lymphocyte-endothelium interaction after cardiac transplantation: in vivo and in vitro studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021

FK778: New Cellular and Molecular Mechanisms of Action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6702727

7 January 2021